SHARMA PANNA

President & CEO at Lantern Pharma Inc. · on record since Jun 15, 2020
Director at Vyant Bio, Inc. · on record since Apr 4, 2013
Chief Executive Officer at Vyant Bio, Inc. · on record since Dec 15, 2014
Director at Lantern Pharma Inc. · on record since Jun 15, 2020

Insider trading activity of SHARMA PANNA

Transactions on record: 13; since Oct 15, 2013

Open-market buys: 3; $6.5K

Open-market sells: 0

Companies traded: 2; last filing Sep 23, 2025

Figures computed from official regulatory filings — .

Companies where SHARMA PANNA has traded

Lantern Pharma Inc.5 tx · Sep 23, 2025
Vyant Bio, Inc.8 tx · $6.5K · Feb 24, 2017

Track record of SHARMA PANNA

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of SHARMA PANNA

Co-insiders of SHARMA PANNA

PRENDERGAST FRANKLYN GLantern Pharma Inc. +1
Asaithambi ArunkumarLantern Pharma Inc.
Bhatia Kishor G.Lantern Pharma Inc.
BIOLOGICAL MIMETICS INCLantern Pharma Inc.
BIOS Advisors GP, LLCLantern Pharma Inc.
BIOS Capital Management, LPLantern Pharma Inc.
Bios Equity Partners II, LPLantern Pharma Inc.
Bios Equity Partners, LPLantern Pharma Inc.
BIOS Fund II, LPLantern Pharma Inc.
BIOS Fund II NT, LPLantern Pharma Inc.
BIOS Fund II QP, LPLantern Pharma Inc.
BIOS Fund I, LPLantern Pharma Inc.
BIOS Fund I QP, LPLantern Pharma Inc.
Boehm MarcusVyant Bio, Inc.
BP Directors, LPLantern Pharma Inc.
Brandt RalfVyant Bio, Inc.
Brownlie Keith LVyant Bio, Inc.
Cannon EdmundVyant Bio, Inc.
Cavu Advisors, LLCLantern Pharma Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Lantern Pharma Inc.Listing on record	Sep 23, 2025	OtherD (derivative)	-76,628	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lantern Pharma Inc.Listing on record	Sep 23, 2025	AwardD (derivative)	76,628	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lantern Pharma Inc.Listing on record	Jul 17, 2024	AwardD (derivative)	70,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lantern Pharma Inc.Listing on record	Aug 9, 2022	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lantern Pharma Inc.Listing on record	Jun 15, 2020	AwardD (derivative)	76,628	—	n/a (No price was disclosed in the filing)		SEC
Vyant Bio, Inc.Listing unverified	Feb 24, 2017	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vyant Bio, Inc.Listing unverified	Mar 17, 2016	Buy	1,000	2.60 USD	$2.6K	conv 48Cluster	SEC
Vyant Bio, Inc.Listing unverified	Mar 17, 2016	Buy	500	2.58 USD	$1.3K	conv 48Cluster	SEC
Vyant Bio, Inc.Listing unverified	Mar 16, 2016	Buy	1,000	2.56 USD	$2.6K	conv 53First in 12mo	SEC
Vyant Bio, Inc.Listing unverified	Dec 15, 2014	Award	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vyant Bio, Inc.Listing unverified	Dec 15, 2014	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vyant Bio, Inc.Listing unverified	May 27, 2014	Award	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vyant Bio, Inc.Listing unverified	Oct 15, 2013	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Lantern Pharma Inc.Listing on record	Sep 23, 2025	OtherD (derivative)	-76,628	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lantern Pharma Inc.Listing on record	Sep 23, 2025	AwardD (derivative)	76,628	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lantern Pharma Inc.Listing on record	Jul 17, 2024	AwardD (derivative)	70,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lantern Pharma Inc.Listing on record	Aug 9, 2022	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lantern Pharma Inc.Listing on record	Jun 15, 2020	AwardD (derivative)	76,628	—	n/a (No price was disclosed in the filing)		SEC
Vyant Bio, Inc.Listing unverified	Feb 24, 2017	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vyant Bio, Inc.Listing unverified	Mar 17, 2016	Buy	1,000	2.60 USD	$2.6K	conv 48Cluster	SEC
Vyant Bio, Inc.Listing unverified	Mar 17, 2016	Buy	500	2.58 USD	$1.3K	conv 48Cluster	SEC
Vyant Bio, Inc.Listing unverified	Mar 16, 2016	Buy	1,000	2.56 USD	$2.6K	conv 53First in 12mo	SEC
Vyant Bio, Inc.Listing unverified	Dec 15, 2014	Award	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vyant Bio, Inc.Listing unverified	Dec 15, 2014	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vyant Bio, Inc.Listing unverified	May 27, 2014	Award	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Vyant Bio, Inc.Listing unverified	Oct 15, 2013	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC